Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitogen-activated protein kinase p38 alpha (p38α or MAPK14) is a serine/threonine kinase belonging to the MAP kinase family. It plays a central role in cellular responses to stress, inflammation, cell differentiation, apoptosis, and immune responses. It is activated by dual phosphorylation by MKK3/MKK4 and regulates numerous transcription factors, influencing gene expression programs. Chronic activation is associated with inflammatory diseases, neurodegeneration, cardiac issues, and muscle diseases. While p38α inhibition has been explored for treating inflammatory and cardiac disorders, clinical outcomes have been mixed.
Kinase inhibition
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitogen-Activated Protein Kinase p38 Alpha (p38α).